3rd Quarter - Report

GRIFOLS SHARED SERVICES NORTH AMERICA, INC. for GRIFOLS SHARED SERVICES NORTH AMERICA INC

Firm
Client
Income
—
Expenses
$450,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1476 / S. 694, Preserving Life-Saving Access to Specialty Medicines in America Act (PLASMA Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program H.R. 1143, Medicare IVIG Access Enhancement Act of 2025 H.R. 2343 , John W. Walsh Alpha-1 Home Infusion Act of 2025 H.R. 2172, Preserving Patient Access to Home Infusion Act S. 1818 / H.R.3546, Prescription Drug Price Relief Act of 2025 S.1587 / H.R.3375, Fair Prescription Drug Prices for Americans Act S.1753, End Price Gouging for Medications Act H.R. 3493, Global Fairness in Drug Pricing Act Issues related to the implementation of P.L. 117-169, The Inflation Reduction Act; drug price negotiations, Part D rebate

Foreign entity interest: Issues related to the delivery of plasma-derived therapies.

LobbyistCovered position, as disclosed
ROSEMARY GARZA —
CHRISTOPHER HEALEY —
KATHERINE PAJEWSKI —
MICHAEL PIERSALL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2172 (119th), H.R. 1476 (119th), S. 694 (119th), S. 1753 (119th), S. 1818 (119th), H.R. 3493 (119th), H.R. 2343 (119th), H.R. 3546 (119th), H.R. 1143 (119th), S. 1587 (119th), H.R. 3375 (119th)

Immigration IMM

Issues related to immigration policy

Foreign entity interest: Issues related to the delivery of plasma-derived therapies

LobbyistCovered position, as disclosed
ROSEMARY GARZA —
CHRISTOPHER HEALEY —
KATHERINE PAJEWSKI —
MICHAEL PIERSALL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FY2026 Appropriations bill for Health and Human Services; Medicare and Medicaid drug pricing and eligibility H.R. 1, One Big, Beautiful Bill Act; Medicare provisions - Most Favored Nations and drug pricing, Medicaid provisions - PBM Reform and eligibility, R&D tax credits

Foreign entity interest: Issues related to the delivery of plasma-derived therapies

LobbyistCovered position, as disclosed
ROSEMARY GARZA —
CHRISTOPHER HEALEY —
KATHERINE PAJEWSKI —
MICHAEL PIERSALL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (119th)

Tariff (miscellaneous tariff bills) TAR

Issues related to tariff policy; tariffs on pharmaceuticals and related products

Foreign entity interest: Issues related to the delivery of plasma-derived therapies

LobbyistCovered position, as disclosed
ROSEMARY GARZA —
CHRISTOPHER HEALEY —
KATHERINE PAJEWSKI —
MICHAEL PIERSALL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.